LightInTheBox Holding Co., Ltd. (NYSE: LITB) ("LightInTheBox" or the "Company"), a global consumer lifestyle company, today announced its unaudited financial results for the fourth quarter and full ...
Long-term extension studies have shown that bimekizumab (Bimzelx) maintains a consistent safety profile for 2 years or more ...
Joseph Thomas, MD, MBA, Fellow of Metabolic and Nutritional Medicine In collaboration with Oxygen Health Systems Abstract ...
Research study shows bezafibrate safely cuts canine hypertriglyceridemia ~85%, even with endocrine disease.
A therapeutic plasma exchange (TPE) recently saved the life of a puppy that overdosed on a non-steroidal anti-inflammatory ...
Record Full year Profit of $8.3 millionRecord Quarterly Profit of $3.3 MillionDelivers Seventh Consecutive Profitable QuarterRegains Quarterly Revenue Growth SINGAPORE ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results